drug discovery

drug discovery

Bristol Myers Squibb plans NVIDIA DGX SuperPOD for drug discovery

by

Bristol Myers Squibb is expanding its NVIDIA infrastructure with a Vera Rubin AI factory designed to support drug discovery, proprietary models, and AI-powered scientific research.

OpenAI just exposed how bad AI still is at real science

by

OpenAI’s new LifeSciBench benchmark was supposed to measure how useful AI can be in scientific research. Instead, it also highlights just how far today’s most advanced models still have to go before they can be trusted with real science.